AIRS
AirSculpt Technologies, Inc.
Medical - Care Facilities
Market Cap$220M
5Y Perf.-77.8%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
AIRS vs ISRG
Revenue, margins, valuation, and 5-year total return — side by side.
ISRG
Intuitive Surgical, Inc.
Medical - Instruments & Supplies
Market Cap$160.32B
5Y Perf.+25.0%
AIRS vs ISRG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | AIRS | ISRG |
|---|---|---|
| Industry | Medical - Care Facilities | Medical - Instruments & Supplies |
| Market Cap | $220M | $160.32B |
| Revenue (TTM) | $158M | $10.58B |
| Net Income (TTM) | $-18M | $2.98B |
| Gross Margin | 64.0% | 66.3% |
| Operating Margin | -9.3% | 30.5% |
| Forward P/E | — | 43.6x |
| Total Debt | $105M | $303M |
| Cash & Equiv. | $8M | $3.37B |
AIRS vs ISRG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
AIRS
ISRG
| Stock | Oct 21 | May 26 | Return |
|---|---|---|---|
| AirSculpt Technolog… (AIRS) | 100 | 22.2 | -77.8% |
| Intuitive Surgical,… (ISRG) | 100 | 125.0 | +25.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AIRS vs ISRG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: ISRG leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. AirSculpt Technologies, Inc. is the stronger pick specifically for dividend income and shareholder returns and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
AIRS
AirSculpt Technologies, Inc.
The Income Pick
AIRS is the clearest fit if your priority is dividends and momentum.
- 0.1% yield; the other pay no meaningful dividend
- +44.9% vs ISRG's -15.1%
Best for: dividends and momentum
ISRG
Intuitive Surgical, Inc.
The Income Pick
ISRG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 1.02
- Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
- 5.6% 10Y total return vs AIRS's -75.3%
Best for: income & stability and growth exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | ISRG | 20.5% revenue growth vs AIRS's -7.9% |
| Quality / Margins | ISRG | 28.2% margin vs AIRS's -11.4% |
| Stability / Safety | ISRG | Beta 1.02 vs AIRS's 3.37, lower leverage |
| Dividends | AIRS | 0.1% yield; the other pay no meaningful dividend |
| Momentum (1Y) | AIRS | +44.9% vs ISRG's -15.1% |
| Efficiency (ROA) | ISRG | 14.8% ROA vs AIRS's -9.0%, ROIC 15.0% vs -0.8% |
AIRS vs ISRG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
FY 2025
AIRS vs ISRG — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLISRGLAGGINGAIRS
AIRSAirSculpt Technologie…
1leads
ISRGIntuitive Surgical, I…
4leads
6 Total Categories
CATEGORYLEADERvs AIRSMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
ISRG6/6
Valuation MetricsMultiples, price ratios, and targets
AIRS4/4
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
ISRG7/8
Total Returns1Y, 3Y, 5Y total returns with dividends
ISRG4/6
Risk & VolatilityBeta, volatility, and downside exposure
ISRG2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
ISRG leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ISRG is the larger business by revenue, generating $10.6B annually — 67.2x AIRS's $158M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to AIRS's -11.4%. On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | AIRSAirSculpt Technol… | ISRGIntuitive Surgica… |
|---|---|---|
| RevenueTrailing 12 months | $158M | $10.6B |
| EBITDAEarnings before interest/tax | -$2M | $3.8B |
| Net IncomeAfter-tax profit | -$18M | $3.0B |
| Free Cash FlowCash after capex | $2M | $2.8B |
| Gross MarginGross profit ÷ Revenue | +64.0% | +66.3% |
| Operating MarginEBIT ÷ Revenue | -9.3% | +30.5% |
| Net MarginNet income ÷ Revenue | -11.4% | +28.2% |
| FCF MarginFCF ÷ Revenue | +1.6% | +26.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -17.8% | +23.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -50.0% | +18.8% |
ISRG leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
AIRS leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, AIRS's 31.4x EV/EBITDA is more attractive than ISRG's 43.4x.
| Metric | AIRSAirSculpt Technol… | ISRGIntuitive Surgica… |
|---|---|---|
| Market CapShares × price | $220M | $160.3B |
| Enterprise ValueMkt cap + debt − cash | $317M | $157.3B |
| Trailing P/EPrice ÷ TTM EPS | -25.14x | 57.35x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 43.64x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.64x |
| EV / EBITDAEnterprise value multiple | 31.43x | 43.41x |
| Price / SalesMarket cap ÷ Revenue | 1.22x | 15.93x |
| Price / BookPrice ÷ Book value/share | 2.56x | 9.12x |
| Price / FCFMarket cap ÷ FCF | — | 64.37x |
AIRS leads this category, winning 4 of 4 comparable metrics.
Profitability & Efficiency
ISRG leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-22 for AIRS. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to AIRS's 1.32x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs AIRS's 2/9, reflecting solid financial health.
| Metric | AIRSAirSculpt Technol… | ISRGIntuitive Surgica… |
|---|---|---|
| ROE (TTM)Return on equity | -21.8% | +16.9% |
| ROA (TTM)Return on assets | -9.0% | +14.8% |
| ROICReturn on invested capital | -0.8% | +15.0% |
| ROCEReturn on capital employed | -1.0% | +16.5% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 6 |
| Debt / EquityFinancial leverage | 1.32x | 0.02x |
| Net DebtTotal debt minus cash | $97M | -$3.1B |
| Cash & Equiv.Liquid assets | $8M | $3.4B |
| Total DebtShort + long-term debt | $105M | $303M |
| Interest CoverageEBIT ÷ Interest expense | -1.82x | — |
ISRG leads this category, winning 7 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
ISRG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ISRG five years ago would be worth $16,151 today (with dividends reinvested), compared to $2,473 for AIRS. Over the past 12 months, AIRS leads with a +44.9% total return vs ISRG's -15.1%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.0% vs AIRS's -11.5% — a key indicator of consistent wealth creation.
| Metric | AIRSAirSculpt Technol… | ISRGIntuitive Surgica… |
|---|---|---|
| YTD ReturnYear-to-date | +90.3% | -19.7% |
| 1-Year ReturnPast 12 months | +44.9% | -15.1% |
| 3-Year ReturnCumulative with dividends | -30.6% | +48.1% |
| 5-Year ReturnCumulative with dividends | -75.3% | +61.5% |
| 10-Year ReturnCumulative with dividends | -75.3% | +560.2% |
| CAGR (3Y)Annualised 3-year return | -11.5% | +14.0% |
ISRG leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
ISRG leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ISRG is the less volatile stock with a 1.02 beta — it tends to amplify market swings less than AIRS's 3.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ISRG currently trades 74.7% from its 52-week high vs AIRS's 29.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | AIRSAirSculpt Technol… | ISRGIntuitive Surgica… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.37x | 1.02x |
| 52-Week HighHighest price in past year | $12.00 | $603.88 |
| 52-Week LowLowest price in past year | $1.51 | $427.84 |
| % of 52W HighCurrent price vs 52-week peak | +29.3% | +74.7% |
| RSI (14)Momentum oscillator 0–100 | 68.0 | 42.5 |
| Avg Volume (50D)Average daily shares traded | 3.1M | 1.8M |
ISRG leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates AIRS as "Hold" and ISRG as "Buy". Consensus price targets imply 70.5% upside for AIRS (target: $6) vs 37.9% for ISRG (target: $623). AIRS is the only dividend payer here at 0.12% yield — a key consideration for income-focused portfolios.
| Metric | AIRSAirSculpt Technol… | ISRGIntuitive Surgica… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $6.00 | $622.60 |
| # AnalystsCovering analysts | 5 | 55 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | — |
| Dividend StreakConsecutive years of raises | 0 | — |
| Dividend / ShareAnnual DPS | $0.00 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | +1.4% |
Insufficient data to determine a leader in this category.
Key Takeaway
ISRG leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AIRS leads in 1 (Valuation Metrics).
Best OverallIntuitive Surgical, Inc. (ISRG)Leads 4 of 6 categories
Loading custom metrics...
AIRS vs ISRG: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is AIRS or ISRG a better buy right now?
For growth investors, Intuitive Surgical, Inc.
(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus -7. 9% for AirSculpt Technologies, Inc. (AIRS). Intuitive Surgical, Inc. (ISRG) offers the better valuation at 57. 4x trailing P/E (43. 6x forward), making it the more compelling value choice. Analysts rate Intuitive Surgical, Inc. (ISRG) a "Buy" — based on 55 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — AIRS or ISRG?
Over the past 5 years, Intuitive Surgical, Inc.
(ISRG) delivered a total return of +61. 5%, compared to -75. 3% for AirSculpt Technologies, Inc. (AIRS). Over 10 years, the gap is even starker: ISRG returned +560. 2% versus AIRS's -75. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — AIRS or ISRG?
By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.
(ISRG) is the lower-risk stock at 1. 02β versus AirSculpt Technologies, Inc. 's 3. 37β — meaning AIRS is approximately 231% more volatile than ISRG relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 132% for AirSculpt Technologies, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — AIRS or ISRG?
By revenue growth (latest reported year), Intuitive Surgical, Inc.
(ISRG) is pulling ahead at 20. 5% versus -7. 9% for AirSculpt Technologies, Inc. (AIRS). On earnings-per-share growth, the picture is similar: Intuitive Surgical, Inc. grew EPS 22. 6% year-over-year, compared to -77. 4% for AirSculpt Technologies, Inc.. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — AIRS or ISRG?
Intuitive Surgical, Inc.
(ISRG) is the more profitable company, earning 28. 4% net margin versus -4. 6% for AirSculpt Technologies, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -1. 0% for AIRS. At the gross margin level — before operating expenses — ISRG leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is AIRS or ISRG more undervalued right now?
Analyst consensus price targets imply the most upside for AIRS: 70.
5% to $6. 00.
07Which pays a better dividend — AIRS or ISRG?
In this comparison, AIRS (0.
1% yield) pays a dividend. ISRG does not pay a meaningful dividend and should not be held primarily for income.
08Is AIRS or ISRG better for a retirement portfolio?
For long-horizon retirement investors, Intuitive Surgical, Inc.
(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +560. 2% 10Y return). AirSculpt Technologies, Inc. (AIRS) carries a higher beta of 3. 37 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISRG: +560. 2%, AIRS: -75. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between AIRS and ISRG?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AIRS is a small-cap quality compounder stock; ISRG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(AIRS: -17.8% · ISRG: 23.0%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.